1Zou S,Musavi F,Notari EP,et al.Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006 [J].Transfusion,2008, 48(12):2531-2539.
7Z H Qian,SH Vermund,N Wang. Risk of HIV/AIDS in China: subpopulations of special importance [J]. Sex Transm Infect, 2005,81:442-447.
8Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003[J]. Euro Surveill, 2005,10(2) :17-19.
9Velati C, Fomiatti L, Baruffi L, et al. Impact of nucleic acid am plification technology (NAT) in Italy in the three years following implementation (2001 - 2003) [J]. Euro Surveill, 2005,10(2) : 12 14.
10Ohnuma H, Tanaka T, Yoshikawa A, et al, Japanese Red Cross NAT Screening Research Group. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV[J]. Microhiol Immunol, 2001,45 (9) :667--672.
